135 related articles for article (PubMed ID: 32993564)
1. Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients.
Wang J; Tong L; Lin G; Wang H; Zhang L; Yang X
BMC Cancer; 2020 Sep; 20(1):931. PubMed ID: 32993564
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
3. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
4. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
5. Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.
Cai J; Chen Q; Cui Y; Dong J; Chen M; Wu P; Jiang C
Oncoimmunology; 2018; 7(5):e1426516. PubMed ID: 29721393
[TBL] [Abstract][Full Text] [Related]
6. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
7. CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma.
Tong L; Li J; Choi J; Pant A; Xia Y; Jackson C; Liu P; Yi L; Boussouf E; Lim M; Yang X
Cancer Gene Ther; 2020 Sep; 27(9):669-679. PubMed ID: 31591460
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
Cho SY; Kim S; Kim G; Singh P; Kim DW
Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
[TBL] [Abstract][Full Text] [Related]
10. CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
Shi H; Song Y; Song Z; Huang C
PLoS One; 2021; 16(1):e0245524. PubMed ID: 33465115
[TBL] [Abstract][Full Text] [Related]
11. The clinical characteristics and prognostic value of IGFBP6 in glioma.
Zong Z; Xin L; Tang X; Guo H
Neurol Res; 2022 Feb; 44(2):113-120. PubMed ID: 34396926
[TBL] [Abstract][Full Text] [Related]
12. Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.
Chen Q; Han B; Meng X; Duan C; Yang C; Wu Z; Magafurov D; Zhao S; Safin S; Jiang C; Cai J
Int J Cancer; 2019 Jul; 145(2):517-530. PubMed ID: 30613962
[TBL] [Abstract][Full Text] [Related]
13. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
14. ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas.
Fan X; Wang Y; Zhang C; Liu L; Yang S; Wang Y; Liu X; Qian Z; Fang S; Qiao H; Jiang T
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571068
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451
[TBL] [Abstract][Full Text] [Related]
16. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
17. Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma.
Xiong Z; Xiong Y; Liu H; Li C; Li X
J Cell Mol Med; 2020 Oct; 24(19):11607-11612. PubMed ID: 32869484
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
[TBL] [Abstract][Full Text] [Related]
20. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
